Jeff Aronin is a man with a heart of gold. He is an innovator and executive at Paragon Biosciences. Paragon Biosciences incubates innovative companies at the forefront of development and research to help individuals suffering from uncommon diseases, or illnesses, that currently have no treatment options available. Aronin’s main objective is to help people and make their lives easier. He is a well-known executive and entrepreneur who has inspired many in the healthcare industry and beyond.
Aronin graduated with a bachelors degree from Northern Illinois University. He also attained his MBA when he attended DePaul University. He is invested in finding treatments for those suffering from conditions that have not been adequately addressed by larger pharmaceutical companies or the healthcare industry in general. As of recent, Aronin and his team have contributed 14 new medications to the pharmaceutical. Jeff takes the necessary steps in order to aid the research and development of Paragon’s portfolio companies by providing financial assistance and strategic guidance.
After 20 years of working in the pharmaceutical industry, one of Jeff’s first successes was Ovation Pharmaceuticals which was later sold for $900 Million. Throughout his career, Jeff has earned plenty of awards and aims to provide those whose time are finite gain longevity. He has helped create a portfolio of multiple companies that he invests in, and provides them with groundbreaking assets. Jeff Aronin is the prime example of a humanitarian, his hard work and dedication will change the future of medicine and many lives to come.
Jeff Aronin is a member of the executive committee of World Business Chicago and a board member of Discover Financial Services as well non-executive chairman of several of Paragon’s portfolio companies. Jeff is working towards developing economic growth and creating more jobs for the community of Chicago.